PetVivo closes Series B Convertible Preferred Stock offering
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 31 2025
0mins
Equity Financing Agreement: PetVivo Holdings has entered a Subscription Agreement for $5 million in equity financing, receiving an initial $600,000 with the option for an additional $4.4 million expected within 60 days.
Product Commercialization: The funds will support the commercialization of PetVivo's products, including SPRYNG with OsteoCushion Technology, which is designed to manage joint pain in animals by restoring proper joint mechanics.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like undefined with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
